We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Magnetic Microneedle Array Robots to Revolutionize Tissue Slicing and Cultivation

By LabMedica International staff writers
Posted on 01 Aug 2024
Print article
Image: Schematic illustration of tumor tissue slicing, manipulation, and cultivation for high-throughput drug screening (Photo courtesy of Xiaoxuan Zhang et al.)
Image: Schematic illustration of tumor tissue slicing, manipulation, and cultivation for high-throughput drug screening (Photo courtesy of Xiaoxuan Zhang et al.)

The cultivation of patient-derived tissues in vitro is essential for accurate diagnosis, targeted treatments, and advancements in tissue engineering. However, traditional methods of tissue slicing and cultivation often do not meet the clinical needs. Addressing this gap, a groundbreaking method has been developed that incorporates a controllable histotomy technique using hierarchical magnetic microneedle array robots. This innovation not only enhances tissue analysis capabilities but also paves the way for personalized medicine and the development of more effective therapies. As this technology evolves, it is anticipated to significantly impact biomedical research and clinical practices.

A team from Nanjing Drum Tower Hospital (Nanjing, China) has pioneered this innovative tissue slicing and cultivation method that promises to transform how primary tissues are managed in medical settings. Described in a research article published in Engineering, the method employs a three-dimensional printed slicing device with a mortise-tenon structure and a pagoda-shaped microneedle array scaffold loaded with magnetic particles. The multilayered structure of the microneedles ensures stable fixation of tissue samples during slicing, preventing slippage. Additionally, the encapsulated magnetic microneedle fragments convert tissue sections into biohybrid microrobots that can be magnetically manipulated for separation, transport, and dynamic culture.

This method was tested with primary pancreatic cancer tissues, which were segmented into small sections and cultured in multilayered microfluidic chips for comprehensive drug screening. The outcomes are promising for clinical application, marking a substantial advancement in the field of precision medicine. The research article also outlines potential enhancements, such as automating the tissue sectioning process and increasing the throughput of the microtomy device. Going forward, the researchers see potential applications of this technology extending beyond cancer to include various types of patient-derived tissues, potentially revolutionizing long-term tissue cultivation and monitoring.

“The development of this controllable histotomy technique marks a significant advancement in the field of tissue engineering and drug screening,” said Jiaming Wu, the editor of Engineering. “By leveraging the capabilities of magnetic microneedle array robots, researchers have been able to create a more efficient and precise method for tissue manipulation and analysis.”

Related Links:
Nanjing Drum Tower Hospital

Gold Member
Pharmacogenetics Panel
VeriDose Core Panel v2.0
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Ultra-Low Temperature Freezer
iUF118-GX
New
Hemoglobin/Haptoglobin Assay
IDK Hemoglobin/Haptoglobin Complex ELISA

Print article

Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.